{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:10:17Z","timestamp":1778220617338,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020875","name":"Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020875","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This retrospective cohort study estimated the healthcare expenditure of infertility treatment in women who survived childhood cancer and analyzed associated factors using data from the French Childhood Cancer Survivor Study (FCCSS) cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>From 2578 women in the FCCSS cohort, 118 exposed who received infertility treatment, aged 18\u201342, were identified based on first recorded drug therapy and\/or in vitro fertilization\/intracytoplasmic sperm injection and\/or medically assisted procreation between 2011 and 2018. Six hundred eight unexposed who had not undergone infertility treatment were selected using propensity score matching. Expenditure related to infertility treatment was estimated as the difference between cases\u2019 expenditures and average expenditures of their controls yearly, over a maximum follow-up period of 4 years unexposed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Average annual expenditure related to infertility treatment per patient over 4 years was 3043 euros (95% CI: 2240; 3845) (in euros 2025). Expenditure peaked during the first 2 years and among women aged 25\u201335. Patients treated with radiotherapy alone had higher average annual expenditure of 4531 euros (95% CI: 1781; 7281). In multivariate analysis, radiotherapy alone and chemotherapy alone were associated with increased annual expenditure of 4382 euros (95% CI: 1102.0; 7661.3) and 2018 euros (95% CI: 97.3; 3937.8), respectively, compared to patients without childhood radiotherapy or chemotherapy. Combined radiotherapy and chemotherapy increased infertility-related expenditure (\u20ac2132.5 (95% CI: \u221236.6; 4301.6),\n                      <jats:italic>p<\/jats:italic>\n                      : 0.054) compared with patients who received neither of these two treatments. The magnitude, trends of expenditure, and age at initiation of infertility treatment were consistent with the general population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion Implications for Cancer Survivors<\/jats:title>\n                    <jats:p>The study shows that childhood cancer treatment modalities significantly influence expenditures related to infertility treatment in women, which are implicitly attributable to the adverse effects of these treatments,with radiotherapy being a key driver. These findings support developing public health strategies promoting more targeted paediatric cancer treatments to mitigate long-term costs, particularly those associated with infertility treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-026-02032-2","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:12:27Z","timestamp":1778217147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infertility costs and associated factors in childhood cancer survivors: the role of radiotherapy"],"prefix":"10.1007","author":[{"given":"Bastien","family":"Bourrion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Panjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Fresneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florent","family":"de Vathaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Pelletier-Fleury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"2032_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017;18:719\u201331. https:\/\/doi.org\/10.1016\/S1470-2045(17)30186-9.","journal-title":"Lancet Oncol"},{"key":"2032_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1470-2045(18)30423-6","volume":"19","author":"E Steliarova-Foucher","year":"2018","unstructured":"Steliarova-Foucher E, Fidler MM, Colombet M, Lacour B, Kaatsch P, Pi\u00f1eros M, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991\u20132010 (Automated Childhood Cancer Information System): a population-based study. Lancet Oncol. 2018;19:1159\u201369. https:\/\/doi.org\/10.1016\/S1470-2045(18)30423-6.","journal-title":"Lancet Oncol"},{"key":"2032_CR3","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1200\/JCO.20.03681","volume":"39","author":"AM Williams","year":"2021","unstructured":"Williams AM, Liu Q, Bhakta N, Krull KR, Hudson MM, Robison LL, et al. Rethinking success in pediatric oncology: beyond 5-year survival. J Clin Oncol. 2021;39:2227\u201331. https:\/\/doi.org\/10.1200\/JCO.20.03681.","journal-title":"J Clin Oncol"},{"key":"2032_CR4","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1158\/1055-9965.EPI-21-0250","volume":"30","author":"T Ghosh","year":"2021","unstructured":"Ghosh T, Chen Y, Dietz AC, Armstrong GT, Howell RM, Smith SA, et al. Lung cancer as a subsequent malignant neoplasm in survivors of childhood cancer. Cancer Epidemiol Biomarkers Prev. 2021;30:2235\u201343. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-0250.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2032_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22689-w","volume":"12","author":"D Bejarano-Quisoboni","year":"2022","unstructured":"Bejarano-Quisoboni D, Pelletier-Fleury N, Allodji RS, Fresneau B, Boussac M, Pacquement H, et al. Long-term hospitalisations in survivors of paediatric solid tumours in France. Sci Rep. 2022;12:18068. https:\/\/doi.org\/10.1038\/s41598-022-22689-w.","journal-title":"Sci Rep"},{"key":"2032_CR6","doi-asserted-by":"publisher","unstructured":"Bejarano-Quisoboni D, Panjo H, Fresneau B, El\u2011Fayech C, Doz F, Surun A, et al. Excess healthcare expenditure in adults treated for solid cancer in childhood: a cohort study in France. Eur J Health Econ. 2023(3). https:\/\/doi.org\/10.1007\/s10198-023-01606-6.","DOI":"10.1007\/s10198-023-01606-6"},{"issue":"22","key":"2032_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02320","volume":"41","author":"JE Bates","year":"2023","unstructured":"Bates JE, Shrestha S, Liu Q, Smith SA, Mulrooney DA, Leisenring W, et al. Cardiac substructure radiation dose and risk of late cardiac disease in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2023;JCO2202320. https:\/\/doi.org\/10.1200\/JCO.22.02320.","journal-title":"J Clin Oncol"},{"key":"2032_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.16077","volume":"6","author":"NS Phillips","year":"2023","unstructured":"Phillips NS, Stratton KL, Williams AM, Ahles T, Ness KK, Cohen HJ, et al. Late-onset cognitive impairment and modifiable risk factors in adult childhood cancer survivors. JAMA Netw Open. 2023;6:e2316077. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.16077.","journal-title":"JAMA Netw Open"},{"key":"2032_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1470-2045(13)70251-1","volume":"14","author":"SE Barton","year":"2013","unstructured":"Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14:873\u201381. https:\/\/doi.org\/10.1016\/S1470-2045(13)70251-1.","journal-title":"Lancet Oncol"},{"key":"2032_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.xfre.2021.08.004","volume":"2","author":"D Garg","year":"2021","unstructured":"Garg D, Meeks HD, Johnstone E, Berga SL, Smith KR, Hotaling J, et al. Cancer treatment is associated with a measurable decrease in live births in a large, population-based study. F S Rep. 2021;2:462\u20137. https:\/\/doi.org\/10.1016\/j.xfre.2021.08.004.","journal-title":"F S Rep"},{"key":"2032_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","volume":"6","author":"WHB Wallace","year":"2005","unstructured":"Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6:209\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(05)70092-9.","journal-title":"Lancet Oncol"},{"key":"2032_CR12","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","volume":"36","author":"W van Dorp","year":"2018","unstructured":"van Dorp W, Haupt R, Anderson RA, Mulder RL, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol. 2018;36:2169\u201380. https:\/\/doi.org\/10.1200\/JCO.2017.76.3441.","journal-title":"J Clin Oncol"},{"key":"2032_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dmz027","volume":"25","author":"N Spears","year":"2019","unstructured":"Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25:673\u201393. https:\/\/doi.org\/10.1093\/humupd\/dmz027.","journal-title":"Hum Reprod Update"},{"key":"2032_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/humrep\/dev060","volume":"30","author":"C Thomas-Teinturier","year":"2015","unstructured":"Thomas-Teinturier C, Allodji RS, Svetlova E, Frey M-A, Oberlin O, Millischer A-E, et al. Ovarian reserve after treatment with alkylating agents during childhood. Hum Reprod. 2015;30:1437\u201346. https:\/\/doi.org\/10.1093\/humrep\/dev060.","journal-title":"Hum Reprod"},{"key":"2032_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-018-0432-0","volume":"16","author":"R Marci","year":"2018","unstructured":"Marci R, Mallozzi M, Di Benedetto L, Schimberni M, Mossa S, Soave I, et al. Radiations and female fertility. Reprod Biol Endocrinol. 2018;16:112. https:\/\/doi.org\/10.1186\/s12958-018-0432-0.","journal-title":"Reprod Biol Endocrinol"},{"key":"2032_CR16","unstructured":"Female Fertility Issues and Cancer \u2014 Side Effects - NCI [Internet]. 2017 [cited 2025 Jan 28]. https:\/\/www.cancer.gov\/about-cancer\/treatment\/side-effects\/fertility-women. Accessed 28 Jan 2025"},{"key":"2032_CR17","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1002\/cam4.5339","volume":"12","author":"K El Alaoui\u2010Lasmaili","year":"2022","unstructured":"El Alaoui\u2010Lasmaili K, Nguyen\u2010Thi PL, Demogeot N, Lighezzolo\u2010Alnot J, Gross MJ, Mansuy L, et al. Fertility discussions and concerns in childhood cancer survivors, a systematic review for updated practice. Cancer Med. 2022;12:6023\u201339. https:\/\/doi.org\/10.1002\/cam4.5339.","journal-title":"Cancer Med"},{"key":"2032_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71045","volume":"14","author":"P Holmer","year":"2025","unstructured":"Holmer P, Ospelt M, Michel G, Lehmann V, Schulte FSM. Fertility\u2010related concerns in survivors of childhood cancer: a systematic review. Cancer Med. 2025;14:e71045. https:\/\/doi.org\/10.1002\/cam4.71045.","journal-title":"Cancer Med"},{"key":"2032_CR19","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1200\/JCO.2016.71.7066","volume":"35","author":"RD Nipp","year":"2017","unstructured":"Nipp RD, Kirchhoff AC, Fair D, Rabin J, Hyland KA, Kuhlthau K, et al. Financial burden in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2017;35:3474\u201381. https:\/\/doi.org\/10.1200\/JCO.2016.71.7066.","journal-title":"J Clin Oncol"},{"key":"2032_CR20","unstructured":"Michael F. Drummond methods for the economic evaluation of health care programmes. 4th ed. Oxford University Press; 2015."},{"key":"2032_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3109\/0284186X.2015.1008648","volume":"54","author":"JF Winther","year":"2015","unstructured":"Winther JF, Kenborg L, Byrne J, Hjorth L, Kaatsch P, Kremer LCM, et al. Childhood cancer survivor cohorts in Europe. Acta Oncol. 2015;54:655\u201368. https:\/\/doi.org\/10.3109\/0284186X.2015.1008648.","journal-title":"Acta Oncol"},{"issue":"Suppl 4","key":"2032_CR22","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","volume":"65","author":"P Tuppin","year":"2017","unstructured":"Tuppin P, Rudant J, Constantinou P, Gastaldi-M\u00e9nager C, Rachas A, de Roquefeuil L, et al. Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65(Suppl 4):S149-67. https:\/\/doi.org\/10.1016\/j.respe.2017.05.004.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2032_CR23","unstructured":"Rey G, Rican S, Jougla E. Measuring inequalities in mortality by cause of death. An ecological approach using an index of social disadvantage. Bull Epid\u00e9miologique Hebd. 2011;87\u201390."},{"key":"2032_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267317","volume":"17","author":"D Bejarano-Quisoboni","year":"2022","unstructured":"Bejarano-Quisoboni D, Pelletier-Fleury N, Allodji RS, Lacour B, GrosClaude P, FRANCIM Group, et al. Health care expenditures among long-term survivors of pediatric solid tumors: results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM). PLoS ONE. 2022;17:e0267317. https:\/\/doi.org\/10.1371\/journal.pone.0267317.","journal-title":"PLoS ONE"},{"key":"2032_CR25","unstructured":"Real World Health Care Data Analysis de Douglas Faries, Xiang Zhang, Zbigniew Kadziola - Livre \u00e9lectronique | Everand [Internet]. [cited 2024 Feb 7]. https:\/\/www.everand.com\/book\/443069330\/Real-World-Health-Care-Data-Analysis-Causal-Methods-and-Implementation-Using-SAS. Accessed 7 Feb 2024"},{"key":"2032_CR26","unstructured":"SAS Help Center: The PSMATCH Procedure [Internet]. [cited 2024 Dec 10]. https:\/\/documentation.sas.com\/doc\/en\/statcdc\/14.2\/statug\/statug_psmatch_toc.htm. Accessed 10 Dec 2024"},{"key":"2032_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07725-9","volume":"22","author":"B Bourrion","year":"2022","unstructured":"Bourrion B, Panjo H, Bithorel P-L, de La Rochebrochard E, Fran\u00e7ois M, Pelletier-Fleury N. The economic burden of infertility treatment and distribution of expenditures overtime in France: a self-controlled pre-post study. BMC Health Serv Res. 2022;22:512. https:\/\/doi.org\/10.1186\/s12913-022-07725-9.","journal-title":"BMC Health Serv Res"},{"key":"2032_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00019053-199405050-00005","volume":"5","author":"BJ O\u2019Brien","year":"1994","unstructured":"O\u2019Brien BJ, Drummond MF. Statistical versus quantitative significance in the socioeconomic evaluation of medicines. Pharmacoeconomics. 1994;5:389\u201398. https:\/\/doi.org\/10.2165\/00019053-199405050-00005.","journal-title":"Pharmacoeconomics"},{"key":"2032_CR29","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1200\/JCO.2008.20.1541","volume":"27","author":"DM Green","year":"2009","unstructured":"Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2677\u201385. https:\/\/doi.org\/10.1200\/JCO.2008.20.1541.","journal-title":"J Clin Oncol"},{"key":"2032_CR30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.2105\/AJPH.2020.305781","volume":"110","author":"K Ben Messaoud","year":"2020","unstructured":"Ben Messaoud K, Bouyer J, de La Rochebrochard E. Infertility treatment in France, 2008\u20132017: a challenge of growing treatment needs at older ages. Am J Public Health. 2020;110:1418\u201320. https:\/\/doi.org\/10.2105\/AJPH.2020.305781.","journal-title":"Am J Public Health"},{"key":"2032_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.fertnstert.2011.12.034","volume":"97","author":"S Lisonkova","year":"2012","unstructured":"Lisonkova S, Joseph KS. Temporal trends in clomiphene citrate use: a population-based study. Fertil Steril. 2012;97:639\u201344. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.12.034.","journal-title":"Fertil Steril"},{"key":"2032_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/pds.5616","volume":"32","author":"B Bourrion","year":"2023","unstructured":"Bourrion B, Panjo H, Fran\u00e7ois M, Pelletier-Fleury N. Trends in clomiphene citrate and gonadotropins use in women with infertility between 2010 and 2017: a population-based study in France. Pharmacoepidemiol Drug Saf. 2023;32:845\u201354. https:\/\/doi.org\/10.1002\/pds.5616.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2032_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamapediatrics.2024.0642","volume":"178","author":"MV Hern\u00e1dfoi","year":"2024","unstructured":"Hern\u00e1dfoi MV, Koch DK, K\u00f3i T, Imrei M, Nagy R, M\u00e1t\u00e9 V, et al. Burden of childhood cancer and the social and economic challenges in adulthood: a systematic review and meta-analysis. JAMA Pediatr. 2024;178:548\u201366. https:\/\/doi.org\/10.1001\/jamapediatrics.2024.0642.","journal-title":"JAMA Pediatr"},{"key":"2032_CR34","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1210\/jc.2016-3723","volume":"102","author":"W Chemaitilly","year":"2017","unstructured":"Chemaitilly W, Li Z, Krasin MJ, Brooke RJ, Wilson CL, Green DM, et al. Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort. J Clin Endocrinol Metab. 2017;102:2242\u201350. https:\/\/doi.org\/10.1210\/jc.2016-3723.","journal-title":"J Clin Endocrinol Metab"},{"key":"2032_CR35","first-page":"604","volume":"67","author":"CB Coulam","year":"1986","unstructured":"Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604\u20136.","journal-title":"Obstet Gynecol"},{"key":"2032_CR36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.31121","volume":"124","author":"JM Levine","year":"2018","unstructured":"Levine JM, Whitton JA, Ginsberg JP, Green DM, Leisenring WM, Stovall M, et al. Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2018;124:1044\u201352. https:\/\/doi.org\/10.1002\/cncr.31121.","journal-title":"Cancer"},{"key":"2032_CR37","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1210\/jc.2015-1690","volume":"100","author":"F de Vathaire","year":"2015","unstructured":"de Vathaire F, Haddy N, Allodji RS, Hawkins M, Guibout C, El-Fayech C, et al. Thyroid radiation dose and other risk factors of thyroid carcinoma following childhood cancer. J Clin Endocrinol Metab. 2015;100:4282\u201390. https:\/\/doi.org\/10.1210\/jc.2015-1690.","journal-title":"J Clin Endocrinol Metab"},{"key":"2032_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.115.016686","volume":"133","author":"N Haddy","year":"2016","unstructured":"Haddy N, Diallo S, El-Fayech C, Schwartz B, Pein F, Hawkins M, et al. Cardiac diseases following childhood cancer treatment: cohort study. Circ. 2016;133:31\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016686.","journal-title":"Circ"},{"key":"2032_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mpo.1316","volume":"38","author":"LL Robison","year":"2002","unstructured":"Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229\u201339. https:\/\/doi.org\/10.1002\/mpo.1316.","journal-title":"Med Pediatr Oncol"},{"key":"2032_CR40","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/bjc.1989.92","volume":"59","author":"F de Vathaire","year":"1989","unstructured":"de Vathaire F, Schweisguth O, Rodary C, Fran\u00e7ois P, Sarrazin D, Oberlin O, et al. Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer. 1989;59:448\u201352. https:\/\/doi.org\/10.1038\/bjc.1989.92.","journal-title":"Br J Cancer"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-026-02032-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:12:30Z","timestamp":1778217150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-026-02032-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":40,"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1007\/s11764-026-02032-2","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No generative AI and AI-assisted technologies was used in the writing process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The study was approved by the French Data Protection Authority (CNIL) (Authorization n \u030a902287) and by the ethics committee of the INSERM. Individual patient informed consent was not required for this study because we obtained a specific act in law from the French \u201cConseil d\u2019Etat\u201d, the highest court in France (Order 2014-96 of 3 February 2014), which approved cession of the SNDS data for all patients included in the FCCSS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}